Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
MARKETS
SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
INDUSTRY : PHARMACEUTICALS
REMUS PHARMACEUTICALS LTD.
Remus Pharmaceuticals Ltd.
NSE: REMUS
Download real time
843.65
15.75
(
1.90
%)
Near 52W Low of ₹819.00
3,300
NSE Volume
NSE
10 Sep, 2025 3:31 PM (IST)
Watchlist
Portfolio
Alert
Share
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
My Notes
Excel Connect
Overview
Buy Sell Zone
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Remus Pharmaceuticals Ltd. Latest Shareholding Pattern - Promoter, FII, DII, Mutual Fund holding
Remus Pharmaceuticals Ltd. shareholding pattern - Promoter holding and pledges, FII, DII, Mutual Fund holding change for the latest quarter.
SHAREHOLDING SUMMARY
HISTORICAL PROMOTOR HOLDING
HISTORICAL MF HOLDING
HISTORICAL FII HOLDING
View all Shareholding Stock Screeners
Quarter Ending
Jul, 07 2025
Jul, 07 2025 (latest)
Mar 2025
Sep 2024
Jun, 10 2024
Mar 2024
Sep 2023
May, 24 2023
Summary Data
Promoter Holding
Institutional Holding
Public (Non-Institutional) Holding
Mutual Fund (Monthly Holdings)
Summary
Jul 07, 2025
Mar 2025
Sep 2024
Jun 10, 2024
Mar 2024
Sep 2023
May 24, 2023
Promoter
70.9%
70.9%
70.8%
70.7%
70.6%
69.6%
68.4%
Holding
70.9%
70.9%
70.8%
70.7%
70.6%
69.6%
68.4%
Pledged
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Locked
28.27%
28.27%
28.27%
28.34%
96.84%
98.22%
100.00%
FII
5.0%
4.8%
3.2%
3%
3.3%
2.4%
2.6%
DII
0.8%
0.8%
0.8%
0.7%
0.7%
0.7%
3.1%
Mutual Funds
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Banks
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.92%
Insurance
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Others
0.79%
0.77%
0.77%
0.73%
0.67%
0.71%
2.14%
Public
23.3%
23.6%
25.2%
25.9%
25.5%
27.3%
26.0%
Others
0.0%
0.0%
0.0%
0%
0.0%
0%
0%
Holding Jul 2025
Holding Mar 2025
Holding Mar 2024
Locked
History
%
shares
%
shares
%
shares
%
shares
70.85
8,349,500
70.85
4,174,750
70.60
1,040,000
28.27
2,360,000
Name
Holding Jul 2025
No of holders
Indian/Foreign
Locked
History
%
shares
%
shares
Individuals/Hindu undivided Family
69.94
8,241,700
8
Indian
28.63
2,360,000
Shah arpit deepakkumar
17.63
2,077,000
-
Indian
28.41
590,000
Roma vinodbhai shah
17.18
2,024,800
-
Indian
29.14
590,000
Anar swapnil shah
16.97
2,000,000
-
Indian
29.50
590,000
Swapnil jatinbhai shah
16.97
2,000,000
-
Indian
29.50
590,000
Hemant ishwarlal modi
1.00
117,600
-
Indian
0.00
0
Mansi aadarsh shah
0.07
8,000
-
Indian
0.00
0
Sonal hemantbhai modi
0.07
8,000
-
Indian
0.00
0
Vinodkumar gandalal shah
0.05
6,300
-
Indian
0.00
0
Any Other (specify)
0.91
107,800
1
Indian
0.00
0
Bodies corporate
0.91
107,800
-
Indian
0.00
0
Renosen pharmaceuticals private limited
0.91
107,800
-
Indian
0.00
0
Holding Jul 2025
Holding Mar 2025
Holding Mar 2024
History
%
shares
%
shares
%
shares
5.82
686,000
5.54
326,700
3.92
57,600
Name
Holding Jul 2025
No of holders
History
%
shares
Foreign Portfolio Investors Category I
5.03
*
592,800
4
India emerging giants fund limited
4.75
559,800
-
Holding Jul 2025
Holding Mar 2025
Holding Mar 2024
History
%
shares
%
shares
%
shares
23.31
2,748,500
23.60
1,390,550
25.47
375,400
Name
Holding Jul 2025
No of holders
History
%
shares
Resident Individuals holding nominal share capital in excess of Rs. 2 lakhs
7.35
866,200
17
Rekha gunavanth kumar
1.09
128,000
-
Individual share capital upto Rs. 2 Lacs
11.54
1,360,400
1,760
Any Other (specify)
3.01
354,900
146
Huf
2.61
308,000
-
Llp
0.26
30,900
-
Director or director's relatives
0.14
16,000
-
Bodies Corporate
1.22
143,800
33
Non Resident Indians (NRIs)
0.18
21,600
45
Shareholding Stock Screeners